tiprankstipranks
Valeo Pharma (VPHIF)
OTHER OTC:VPHIF
US Market
VPHIF
Valeo Pharma
RESEARCH TOOLSreports

Valeo Pharma (VPHIF) Financial Statements

14 Followers

Valeo Pharma Financial Overview

Valeo Pharma's market cap is currently $3.18M. The company's EPS TTM is $; its P/E ratio is ―; Valeo Pharma is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 23Oct 22Jan 22Jan 21Jan 20
Income Statement
Total RevenueC$ 53.91MC$ 27.75MC$ 13.56MC$ 7.47MC$ 6.58M
Gross ProfitC$ 13.08MC$ 6.28MC$ 3.96MC$ 1.38MC$ 1.40M
Operating IncomeC$ -17.23MC$ -19.60MC$ -12.82MC$ -4.34MC$ -3.54M
EBITDAC$ -11.39MC$ -16.10MC$ -10.97MC$ -3.74MC$ -3.41M
Net IncomeC$ -27.81MC$ -25.75MC$ -14.23MC$ -4.76MC$ -3.62M
Balance Sheet
Cash & Short-Term InvestmentsC$ 7.50MC$ 22.50MC$ 2.04MC$ 2.84MC$ 335.00K
Total AssetsC$ 41.21MC$ 58.27MC$ 21.03MC$ 10.96MC$ 5.81M
Total DebtC$ 65.17MC$ 61.44MC$ 7.67MC$ 3.26MC$ 1.00M
Net DebtC$ 57.67MC$ 38.94MC$ 5.63MC$ 426.00KC$ 666.00K
Total LiabilitiesC$ 81.54MC$ 76.11MC$ 18.98MC$ 7.89MC$ 5.83M
Stockholders' EquityC$ -40.34MC$ -17.85MC$ 2.05MC$ 3.07MC$ -22.00K
Cash Flow
Free Cash FlowC$ -21.25MC$ -35.39MC$ -15.78MC$ -6.70MC$ -3.25M
Operating Cash FlowC$ -15.70MC$ -28.50MC$ -12.31MC$ -5.30MC$ -2.31M
Investing Cash FlowC$ -5.55MC$ -6.89MC$ -3.46MC$ -1.41MC$ -923.00K
Financing Cash FlowC$ 6.19MC$ 54.99MC$ 15.10MC$ 9.21MC$ 3.55M
Currency in CAD

Valeo Pharma Earnings and Revenue History

Income Statement >

Valeo Pharma Debt to Assets

Balance Sheet >

Valeo Pharma Cash Flow

Cash Flow >

Valeo Pharma Forecast EPS vs Actual EPS

Earnings >